Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
L01AX03
|
| gptkbp:CASNumber |
85622-93-1
|
| gptkbp:hasInChIKey |
TZIKCAFNXDKGEX-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C6H6N6O2
|
| gptkbp:hasPatentExpiry |
2013 (US)
|
| gptkbp:hasSMILES |
CN(C)C(=O)N1C=NC2=NC=NN21
|
| gptkbp:hasTherapeuticUse |
treatment of anaplastic astrocytoma
treatment of glioblastoma |
| gptkbp:hasUNII |
J41CSQ7QDS
|
| https://www.w3.org/2000/01/rdf-schema#label |
C10483
|
| gptkbp:KEGGID |
D06053
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
antineoplastic agent
|
| gptkbp:meltingPoint |
212-214°C
|
| gptkbp:molecularWeight |
194.15 g/mol
|
| gptkbp:name |
gptkb:Temozolomide
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
5394
CHEMBL177 DB00853 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting fatigue myelosuppression |
| gptkbp:status |
FDA approved
EMA approved |
| gptkbp:synonym |
gptkb:NSC_362856
gptkb:SCH_52365 gptkb:Temodal gptkb:Temodar gptkb:Temozolomideum CCRG 81045 |
| gptkbp:bfsParent |
gptkb:Safrole
|
| gptkbp:bfsLayer |
6
|